Copyright
©The Author(s) 2017.
World J Diabetes. Apr 15, 2017; 8(4): 143-153
Published online Apr 15, 2017. doi: 10.4239/wjd.v8.i4.143
Published online Apr 15, 2017. doi: 10.4239/wjd.v8.i4.143
Figure 5 Activation of glucose transport in human adipocytes by supramicromolar doses of B6V10.
Suspensions of human fat cells (17 mg/400 μL) were incubated 45 min without (basal, open circle) or the indicated concentrations of insulin (closed circles), B6V10 (red diamonds), benzylamine (open squares), and 100 μmol/L vanadate alone (yellow triangle) or in combination with benzylamine (closed triangles), then [3H]-2-deoxyglucose uptake was assayed on 10-min period. Mean ± SEM of 10 adipocyte preparations. Significantly different from basal uptake at: aP < 0.05, dP < 0.01, fP < 0.001.
- Citation: Carpéné C, Garcia-Vicente S, Serrano M, Marti L, Belles C, Royo M, Galitzky J, Zorzano A, Testar X. Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells. World J Diabetes 2017; 8(4): 143-153
- URL: https://www.wjgnet.com/1948-9358/full/v8/i4/143.htm
- DOI: https://dx.doi.org/10.4239/wjd.v8.i4.143